"Not just Serum Institute of India, all the vaccine companies should get indemnity protection against liabilities if foreign companies are granted the same," sources told ANI. As the government is expanding the vaccination drive in phases, it is actively looking into roping in foreign vaccine manufacturers. "We need to have the government indemnify manufacturers, especially vaccine manufacturers, against all lawsuits... The government needs to step in with the right messaging," Serum Institute CEO Adar Poonawalla had said earlier. In 2020, a Chennai man who took part in the trial of Covishield sought ₹5 crore compensation from Serum Institute, alleging side effects.

Source: Hindustan Times June 03, 2021 09:28 UTC